GLS2 and hepatocellular carcinoma: To confirm the role of GLS1 and GLS2 in the regulation of HCC proliferation, we introduced three inhibitors: CB‐839, bis‐2‐(5‐phenylacetamido‐1,3,4‐thiadiazol‐2‐yl)ethyl sulfide (BPTES) and Compound 968 (968).